APO Research
Talk to an analyst

APO RESEARCH · REPORT

Naldemedine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Naldemedine Market Analysis and Forecast 2026-2032

23 December 2025196 pages

Choose your research edition.

Industry ResearchNaldemedine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Naldemedine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Naldemedine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Naldemedine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Naldemedine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Naldemedine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Naldemedine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Naldemedine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Naldemedine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Naldemedine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Naldemedine include Purdue Pharma and Shionogi etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Naldemedine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Naldemedine, also provides the sales of main regions and countries. Of the upcoming market potential for Naldemedine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Naldemedine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Naldemedine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Naldemedine sales, projected growth trends, production technology, application and end-user industry.

Naldemedine Segment by Company

Purdue Pharma

Shionogi

Naldemedine Segment by Type

Self-production API

Outsourcing of API

Naldemedine Segment by Application

Clinic

Hospital

Drug Center

Others

Naldemedine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naldemedine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Naldemedine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naldemedine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Naldemedine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Naldemedine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Naldemedine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Naldemedine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Self-production API Major Manufacturers Table 3. Outsourcing of API Major Manufacturers Table 4. Global Naldemedine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Clinic Major Manufacturers Table 6. Hospital Major Manufacturers Table 7. Drug Center Major Manufacturers Table 8. Others Major Manufacturers Table 9. Naldemedine Industry Trends Table 10. Naldemedine Industry Drivers Table 11. Naldemedine Industry Opportunities and Challenges Table 12. Naldemedine Industry Restraints Table 13. Global Naldemedine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Naldemedine Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Naldemedine Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Naldemedine Revenue Market Share by Region (2021-2026) Table 17. Global Naldemedine Revenue Market Share by Region (2027-2032) Table 18. Global Naldemedine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 19. Global Naldemedine Sales by Region (2021-2026) & (k pcs) Table 20. Global Naldemedine Sales by Region (2027-2032) & (k pcs) Table 21. Global Naldemedine Sales Market Share by Region (2021-2026) Table 22. Global Naldemedine Sales Market Share by Region (2027-2032) Table 23. Global Naldemedine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Naldemedine Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Naldemedine Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Naldemedine Sales Market Share by Manufacturers (2021-2026) Table 27. Global Naldemedine Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 28. Global Naldemedine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Naldemedine Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Naldemedine Manufacturers, Product Type & Application Table 31. Global Naldemedine Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Naldemedine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Naldemedine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Naldemedine Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Naldemedine Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Naldemedine Revenue Market Share by Type (2021-2026) Table 38. Global Naldemedine Revenue Market Share by Type (2027-2032) Table 39. Global Naldemedine Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 40. Global Naldemedine Sales by Type (2021-2026) & (k pcs) Table 41. Global Naldemedine Sales by Type (2027-2032) & (k pcs) Table 42. Global Naldemedine Sales Market Share by Type (2021-2026) Table 43. Global Naldemedine Sales Market Share by Type (2027-2032) Table 44. Global Naldemedine Price by Type (2021-2026) & (US$/pcs) Table 45. Global Naldemedine Price by Type (2027-2032) & (US$/pcs) Table 46. Global Naldemedine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Naldemedine Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Naldemedine Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Naldemedine Revenue Market Share by Application (2021-2026) Table 50. Global Naldemedine Revenue Market Share by Application (2027-2032) Table 51. Global Naldemedine Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 52. Global Naldemedine Sales by Application (2021-2026) & (k pcs) Table 53. Global Naldemedine Sales by Application (2027-2032) & (k pcs) Table 54. Global Naldemedine Sales Market Share by Application (2021-2026) Table 55. Global Naldemedine Sales Market Share by Application (2027-2032) Table 56. Global Naldemedine Price by Application (2021-2026) & (US$/pcs) Table 57. Global Naldemedine Price by Application (2027-2032) & (US$/pcs) Table 58. Purdue Pharma Company Information Table 59. Purdue Pharma Business Overview Table 60. Purdue Pharma Naldemedine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 61. Purdue Pharma Naldemedine Product Portfolio Table 62. Purdue Pharma Recent Development Table 63. Shionogi Company Information Table 64. Shionogi Business Overview Table 65. Shionogi Naldemedine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 66. Shionogi Naldemedine Product Portfolio Table 67. Shionogi Recent Development Table 68. North America Naldemedine Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Naldemedine Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Naldemedine Sales by Type (2021-2026) & (k pcs) Table 71. North America Naldemedine Sales by Type (2027-2032) & (k pcs) Table 72. North America Naldemedine Sales Price by Type (2021-2026) & (US$/pcs) Table 73. North America Naldemedine Sales Price by Type (2027-2032) & (US$/pcs) Table 74. North America Naldemedine Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Naldemedine Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Naldemedine Sales by Application (2021-2026) & (k pcs) Table 77. North America Naldemedine Sales by Application (2027-2032) & (k pcs) Table 78. North America Naldemedine Sales Price by Application (2021-2026) & (US$/pcs) Table 79. North America Naldemedine Sales Price by Application (2027-2032) & (US$/pcs) Table 80. North America Naldemedine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Naldemedine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Naldemedine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Naldemedine Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 84. North America Naldemedine Sales by Country (2021-2026) & (k pcs) Table 85. North America Naldemedine Sales by Country (2027-2032) & (k pcs) Table 86. North America Naldemedine Sales Price by Country (2021-2026) & (US$/pcs) Table 87. North America Naldemedine Sales Price by Country (2027-2032) & (US$/pcs) Table 88. United States Naldemedine Revenue (2021-2032) & (US$ Million) Table 89. Canada Naldemedine Revenue (2021-2032) & (US$ Million) Table 90. Mexico Naldemedine Revenue (2021-2032) & (US$ Million) Table 91. Europe Naldemedine Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Naldemedine Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Naldemedine Sales by Type (2021-2026) & (k pcs) Table 94. Europe Naldemedine Sales by Type (2027-2032) & (k pcs) Table 95. Europe Naldemedine Sales Price by Type (2021-2026) & (US$/pcs) Table 96. Europe Naldemedine Sales Price by Type (2027-2032) & (US$/pcs) Table 97. Europe Naldemedine Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Naldemedine Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Naldemedine Sales by Application (2021-2026) & (k pcs) Table 100. Europe Naldemedine Sales by Application (2027-2032) & (k pcs) Table 101. Europe Naldemedine Sales Price by Application (2021-2026) & (US$/pcs) Table 102. Europe Naldemedine Sales Price by Application (2027-2032) & (US$/pcs) Table 103. Europe Naldemedine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Naldemedine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Naldemedine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Naldemedine Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 107. Europe Naldemedine Sales by Country (2021-2026) & (k pcs) Table 108. Europe Naldemedine Sales by Country (2027-2032) & (k pcs) Table 109. Europe Naldemedine Sales Price by Country (2021-2026) & (US$/pcs) Table 110. Europe Naldemedine Sales Price by Country (2027-2032) & (US$/pcs) Table 111. Germany Naldemedine Revenue (2021-2032) & (US$ Million) Table 112. France Naldemedine Revenue (2021-2032) & (US$ Million) Table 113. U.K. Naldemedine Revenue (2021-2032) & (US$ Million) Table 114. Italy Naldemedine Revenue (2021-2032) & (US$ Million) Table 115. Russia Naldemedine Revenue (2021-2032) & (US$ Million) Table 116. Spain Naldemedine Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Naldemedine Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Naldemedine Revenue (2021-2032) & (US$ Million) Table 119. Sweden Naldemedine Revenue (2021-2032) & (US$ Million) Table 120. Poland Naldemedine Revenue (2021-2032) & (US$ Million) Table 121. China Naldemedine Revenue by Type (2021-2026) & (US$ Million) Table 122. China Naldemedine Revenue by Type (2027-2032) & (US$ Million) Table 123. China Naldemedine Sales by Type (2021-2026) & (k pcs) Table 124. China Naldemedine Sales by Type (2027-2032) & (k pcs) Table 125. China Naldemedine Sales Price by Type (2021-2026) & (US$/pcs) Table 126. China Naldemedine Sales Price by Type (2027-2032) & (US$/pcs) Table 127. China Naldemedine Revenue by Application (2021-2026) & (US$ Million) Table 128. China Naldemedine Revenue by Application (2027-2032) & (US$ Million) Table 129. China Naldemedine Sales by Application (2021-2026) & (k pcs) Table 130. China Naldemedine Sales by Application (2027-2032) & (k pcs) Table 131. China Naldemedine Sales Price by Application (2021-2026) & (US$/pcs) Table 132. China Naldemedine Sales Price by Application (2027-2032) & (US$/pcs) Table 133. Asia Naldemedine Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Naldemedine Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Naldemedine Sales by Type (2021-2026) & (k pcs) Table 136. Asia Naldemedine Sales by Type (2027-2032) & (k pcs) Table 137. Asia Naldemedine Sales Price by Type (2021-2026) & (US$/pcs) Table 138. Asia Naldemedine Sales Price by Type (2027-2032) & (US$/pcs) Table 139. Asia Naldemedine Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Naldemedine Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Naldemedine Sales by Application (2021-2026) & (k pcs) Table 142. Asia Naldemedine Sales by Application (2027-2032) & (k pcs) Table 143. Asia Naldemedine Sales Price by Application (2021-2026) & (US$/pcs) Table 144. Asia Naldemedine Sales Price by Application (2027-2032) & (US$/pcs) Table 145. Asia Naldemedine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Naldemedine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Naldemedine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Naldemedine Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 149. Asia Naldemedine Sales by Country (2021-2026) & (k pcs) Table 150. Asia Naldemedine Sales by Country (2027-2032) & (k pcs) Table 151. Asia Naldemedine Sales Price by Country (2021-2026) & (US$/pcs) Table 152. Asia Naldemedine Sales Price by Country (2027-2032) & (US$/pcs) Table 153. Japan Naldemedine Revenue (2021-2032) & (US$ Million) Table 154. South Korea Naldemedine Revenue (2021-2032) & (US$ Million) Table 155. India Naldemedine Revenue (2021-2032) & (US$ Million) Table 156. Australia Naldemedine Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Naldemedine Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Naldemedine Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Naldemedine Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Naldemedine Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Naldemedine Sales by Type (2021-2026) & (k pcs) Table 162. SAMEA Naldemedine Sales by Type (2027-2032) & (k pcs) Table 163. SAMEA Naldemedine Sales Price by Type (2021-2026) & (US$/pcs) Table 164. SAMEA Naldemedine Sales Price by Type (2027-2032) & (US$/pcs) Table 165. SAMEA Naldemedine Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Naldemedine Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Naldemedine Sales by Application (2021-2026) & (k pcs) Table 168. SAMEA Naldemedine Sales by Application (2027-2032) & (k pcs) Table 169. SAMEA Naldemedine Sales Price by Application (2021-2026) & (US$/pcs) Table 170. SAMEA Naldemedine Sales Price by Application (2027-2032) & (US$/pcs) Table 171. SAMEA Naldemedine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Naldemedine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Naldemedine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Naldemedine Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 175. SAMEA Naldemedine Sales by Country (2021-2026) & (k pcs) Table 176. SAMEA Naldemedine Sales by Country (2027-2032) & (k pcs) Table 177. SAMEA Naldemedine Sales Price by Country (2021-2026) & (US$/pcs) Table 178. SAMEA Naldemedine Sales Price by Country (2027-2032) & (US$/pcs) Table 179. Brazil Naldemedine Revenue (2021-2032) & (US$ Million) Table 180. Argentina Naldemedine Revenue (2021-2032) & (US$ Million) Table 181. Chile Naldemedine Revenue (2021-2032) & (US$ Million) Table 182. Colombia Naldemedine Revenue (2021-2032) & (US$ Million) Table 183. Peru Naldemedine Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Naldemedine Revenue (2021-2032) & (US$ Million) Table 185. Israel Naldemedine Revenue (2021-2032) & (US$ Million) Table 186. UAE Naldemedine Revenue (2021-2032) & (US$ Million) Table 187. Turkey Naldemedine Revenue (2021-2032) & (US$ Million) Table 188. Iran Naldemedine Revenue (2021-2032) & (US$ Million) Table 189. Egypt Naldemedine Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Naldemedine Distributors List Table 193. Naldemedine Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Naldemedine Image Figure 2. Global Naldemedine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Naldemedine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Self-production API Image Figure 5. Outsourcing of API Image Figure 6. Global Naldemedine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Naldemedine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Clinic Image Figure 9. Hospital Image Figure 10. Drug Center Image Figure 11. Others Image Figure 12. Global Naldemedine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Naldemedine Revenue (2021-2032) & (US$ Million) Figure 14. Global Naldemedine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Naldemedine Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Naldemedine Revenue Market Share by Region (2021-2032) Figure 17. Global Naldemedine Sales (2021-2032) & (k pcs) Figure 18. Global Naldemedine Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 19. Global Naldemedine Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Naldemedine Sales YoY (2021-2032) & (k pcs) Figure 21. Europe Naldemedine Sales YoY (2021-2032) & (k pcs) Figure 22. China Naldemedine Sales YoY (2021-2032) & (k pcs) Figure 23. Asia (Excluding China) Naldemedine Sales YoY (2021-2032) & (k pcs) Figure 24. South America, Middle East and Africa Naldemedine Sales YoY (2021-2032) & (k pcs) Figure 25. Global Naldemedine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Naldemedine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Naldemedine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Naldemedine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Naldemedine Revenue Market Share by Type (2021-2032) Figure 31. Global Naldemedine Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 32. Global Naldemedine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Naldemedine Sales Market Share by Type (2021-2032) Figure 34. Global Naldemedine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Naldemedine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Naldemedine Revenue Market Share by Application (2021-2032) Figure 37. Global Naldemedine Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 38. Global Naldemedine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Naldemedine Sales Market Share by Application (2021-2032) Figure 40. North America Naldemedine Revenue Share by Type (2021-2032) Figure 41. North America Naldemedine Sales Share by Type (2021-2032) Figure 42. North America Naldemedine Revenue Share by Application (2021-2032) Figure 43. North America Naldemedine Sales Share by Application (2021-2032) Figure 44. North America Naldemedine Revenue Share by Country (2021-2032) Figure 45. North America Naldemedine Sales Share by Country (2021-2032) Figure 46. Europe Naldemedine Revenue Share by Type (2021-2032) Figure 47. Europe Naldemedine Sales Share by Type (2021-2032) Figure 48. Europe Naldemedine Revenue Share by Application (2021-2032) Figure 49. Europe Naldemedine Sales Share by Application (2021-2032) Figure 50. Europe Naldemedine Revenue Share by Country (2021-2032) Figure 51. Europe Naldemedine Sales Share by Country (2021-2032) Figure 52. China Naldemedine Revenue Share by Type (2021-2032) Figure 53. China Naldemedine Sales Share by Type (2021-2032) Figure 54. China Naldemedine Revenue Share by Application (2021-2032) Figure 55. China Naldemedine Sales Share by Application (2021-2032) Figure 56. Asia Naldemedine Revenue Share by Type (2021-2032) Figure 57. Asia Naldemedine Sales Share by Type (2021-2032) Figure 58. Asia Naldemedine Revenue Share by Application (2021-2032) Figure 59. Asia Naldemedine Sales Share by Application (2021-2032) Figure 60. Asia Naldemedine Revenue Share by Country (2021-2032) Figure 61. Asia Naldemedine Sales Share by Country (2021-2032) Figure 62. SAMEA Naldemedine Revenue Share by Type (2021-2032) Figure 63. SAMEA Naldemedine Sales Share by Type (2021-2032) Figure 64. SAMEA Naldemedine Revenue Share by Application (2021-2032) Figure 65. SAMEA Naldemedine Sales Share by Application (2021-2032) Figure 66. SAMEA Naldemedine Revenue Share by Country (2021-2032) Figure 67. SAMEA Naldemedine Sales Share by Country (2021-2032) Figure 68. Naldemedine Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Naldemedine Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Self-production API
  • Outsourcing of API
Applications
  • Clinic
  • Hospital
  • Drug Center
  • Others
Companies covered
  • Purdue Pharma
  • Shionogi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Naldemedine Market by Type
  3. 1.2.1 Global Naldemedine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Self-production API
  5. 1.2.3 Outsourcing of API
  6. 1.3 Naldemedine Market by Application
  7. 1.3.1 Global Naldemedine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Clinic
  9. 1.3.3 Hospital
  10. 1.3.4 Drug Center
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Naldemedine Market Dynamics
  1. 2.1 Naldemedine Industry Trends
  2. 2.2 Naldemedine Industry Drivers
  3. 2.3 Naldemedine Industry Opportunities and Challenges
  4. 2.4 Naldemedine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Naldemedine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Naldemedine Revenue by Region
  3. 3.2.1 Global Naldemedine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Naldemedine Revenue by Region (2021-2026)
  5. 3.2.3 Global Naldemedine Revenue by Region (2027-2032)
  6. 3.2.4 Global Naldemedine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Naldemedine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Naldemedine Sales by Region
  9. 3.4.1 Global Naldemedine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Naldemedine Sales by Region (2021-2026)
  11. 3.4.3 Global Naldemedine Sales by Region (2027-2032)
  12. 3.4.4 Global Naldemedine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Naldemedine Revenue by Manufacturers
  2. 4.1.1 Global Naldemedine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Naldemedine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Naldemedine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Naldemedine Sales by Manufacturers
  6. 4.2.1 Global Naldemedine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Naldemedine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Naldemedine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Naldemedine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Naldemedine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Naldemedine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Naldemedine Manufacturers, Product Type & Application
  13. 4.7 Global Naldemedine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Naldemedine Market CR5 and HHI
  16. 4.8.2 2025 Naldemedine Tier 1, Tier 2, and Tier 3
5 Naldemedine Market by Type
  1. 5.1 Global Naldemedine Revenue by Type
  2. 5.1.1 Global Naldemedine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Naldemedine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Naldemedine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Naldemedine Sales by Type
  6. 5.2.1 Global Naldemedine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Naldemedine Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Naldemedine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Naldemedine Price by Type
6 Naldemedine Market by Application
  1. 6.1 Global Naldemedine Revenue by Application
  2. 6.1.1 Global Naldemedine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Naldemedine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Naldemedine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Naldemedine Sales by Application
  6. 6.2.1 Global Naldemedine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Naldemedine Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Naldemedine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Naldemedine Price by Application
7 Company Profiles
  1. 7.1 Purdue Pharma
  2. 7.1.1 Purdue Pharma Company Information
  3. 7.1.2 Purdue Pharma Business Overview
  4. 7.1.3 Purdue Pharma Naldemedine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Purdue Pharma Naldemedine Product Portfolio
  6. 7.1.5 Purdue Pharma Recent Developments
  7. 7.2 Shionogi
  8. 7.2.1 Shionogi Company Information
  9. 7.2.2 Shionogi Business Overview
  10. 7.2.3 Shionogi Naldemedine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shionogi Naldemedine Product Portfolio
  12. 7.2.5 Shionogi Recent Developments
8 North America
  1. 8.1 North America Naldemedine Market Size by Type
  2. 8.1.1 North America Naldemedine Revenue by Type (2021-2032)
  3. 8.1.2 North America Naldemedine Sales by Type (2021-2032)
  4. 8.1.3 North America Naldemedine Price by Type (2021-2032)
  5. 8.2 North America Naldemedine Market Size by Application
  6. 8.2.1 North America Naldemedine Revenue by Application (2021-2032)
  7. 8.2.2 North America Naldemedine Sales by Application (2021-2032)
  8. 8.2.3 North America Naldemedine Price by Application (2021-2032)
  9. 8.3 North America Naldemedine Market Size by Country
  10. 8.3.1 North America Naldemedine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Naldemedine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Naldemedine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Naldemedine Market Size by Type
  2. 9.1.1 Europe Naldemedine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Naldemedine Sales by Type (2021-2032)
  4. 9.1.3 Europe Naldemedine Price by Type (2021-2032)
  5. 9.2 Europe Naldemedine Market Size by Application
  6. 9.2.1 Europe Naldemedine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Naldemedine Sales by Application (2021-2032)
  8. 9.2.3 Europe Naldemedine Price by Application (2021-2032)
  9. 9.3 Europe Naldemedine Market Size by Country
  10. 9.3.1 Europe Naldemedine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Naldemedine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Naldemedine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Naldemedine Market Size by Type
  2. 10.1.1 China Naldemedine Revenue by Type (2021-2032)
  3. 10.1.2 China Naldemedine Sales by Type (2021-2032)
  4. 10.1.3 China Naldemedine Price by Type (2021-2032)
  5. 10.2 China Naldemedine Market Size by Application
  6. 10.2.1 China Naldemedine Revenue by Application (2021-2032)
  7. 10.2.2 China Naldemedine Sales by Application (2021-2032)
  8. 10.2.3 China Naldemedine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Naldemedine Market Size by Type
  2. 11.1.1 Asia Naldemedine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Naldemedine Sales by Type (2021-2032)
  4. 11.1.3 Asia Naldemedine Price by Type (2021-2032)
  5. 11.2 Asia Naldemedine Market Size by Application
  6. 11.2.1 Asia Naldemedine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Naldemedine Sales by Application (2021-2032)
  8. 11.2.3 Asia Naldemedine Price by Application (2021-2032)
  9. 11.3 Asia Naldemedine Market Size by Country
  10. 11.3.1 Asia Naldemedine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Naldemedine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Naldemedine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Naldemedine Market Size by Type
  2. 12.1.1 SAMEA Naldemedine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Naldemedine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Naldemedine Price by Type (2021-2032)
  5. 12.2 SAMEA Naldemedine Market Size by Application
  6. 12.2.1 SAMEA Naldemedine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Naldemedine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Naldemedine Price by Application (2021-2032)
  9. 12.3 SAMEA Naldemedine Market Size by Country
  10. 12.3.1 SAMEA Naldemedine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Naldemedine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Naldemedine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Naldemedine Value Chain Analysis
  2. 13.1.1 Naldemedine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Naldemedine Production Mode & Process
  6. 13.2 Naldemedine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Naldemedine Distributors
  9. 13.2.3 Naldemedine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst